On August 11th, 2017 the NIH published an RFI seeking feedback from stakeholders and the general public on the ECHO-wide Cohort Data Collection Protocol. The RFI specifically requested feedback and recommendations on the data element concepts, types of biospecimens, and innovative data collection methodology. The NIH received a number of responses from researchers, professional organizations, nonprofit organizations, and research foundations. View the responses to this RFI here. The NIH thanks all responders for their input.
Experts plan clinical trial to test treatments for withdrawal syndrome.
The National Institutes of Health is funding a new study to evaluate treatment options for newborns with opioid withdrawal syndrome, a condition caused by exposure to opioids during pregnancy. Currently, health care providers in the United States lack standard, evidence-based treatments for neonatal opioid withdrawal syndrome, despite states reporting more cases in recent years. The study, called Advancing Clinical Trials in Neonatal Opioid Withdrawal Syndrome (ACT NOW), aims to inform clinical care of these infants.
ACT NOW is funded by NIH’s Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the NIH Office of the Director’s Environmental Influences on Child Health Outcomes (ECHO) Program.
Opioids are a class of drugs commonly prescribed for pain relief. Prescriptions for these drugs have quadrupled since 1999 in the United States, putting more reproductive-age women at risk of developing opioid use disorder. Use of these drugs during pregnancy can affect the health and well-being of women and lead to withdrawal symptoms in newborns. Symptoms often include tremors, excessive crying, sleep deprivation and swallowing difficulties.
Read the full press release here to learn more about this study.
ECHO Program Director Matthew Gillman spoke with the Washington Post about the effect of environmental factors on childhood obesity. The article, which looks specifically at obesity research in the context of the ECHO Program, features a Q&A with Dr. Gillman. Read the interview here.
On August 10, 2017, the National Institutes of Health (NIH) released a Request for Information (RFI) to solicit input from a wide variety of stakeholders on the Environmental influences on Child Health Outcomes (ECHO)-wide Cohort Data Collection Protocol. Stakeholders that the NIH hopes will respond to the RFI include: non-ECHO researchers, advocacy groups, professional organizations, and the general public. Comments are due by September 13, 2017. For more information and to contribute, please visit: https://grants.nih.gov/grants/guide/notice-files/NOT-OD-17-090.html.
Environmental influences on Child Health Outcomes (ECHO) is a nationwide NIH-funded research program whose mission is to enhance the health of children for generations to come. The program consists of observational and intervention components. This RFI pertains to the observational component, the ECHO Pediatric Cohorts. The overall scientific goal of the ECHO Pediatric Cohorts is to investigate associations of a broad array of early environmental influences with child health and development. ECHO prioritizes addressing research questions that have impact on policies, practices, and programs.